New technology is allowing us to probe the dark matter of the genome, providing further evidence for John Mattick’s no-longer controversial argument that much of the genome, previously thought to be junk DNA, actually codes for a vast network of regulatory RNAs. [ + ]

ResMed, CSL, Biota, Sonic Healthcare, ChemGenex, Sirtex [ + ]

Adult muscle stem cells rather than embryonic stem cells could be the key to treating muscular disorders. [ + ]

Anti-anxiety drug, BNC210, to undergo phase I clinical trial in Adelaide. [ + ]

Hormone adiponectin could be used to better diagnose and treat type 2 diabetes. [ + ]

Calls for Australian Government to lift moratorium on xenotransplantation so similar trials can occur here. [ + ]

COH, CSL, RHC, ANN, SRX [ + ]

Researchers have been able to differentiate not only between healthy and cancerous cells but also between metastatic and non-metastatic cancer cells using an array of nanoparticles and polymers.

CSL to evaluate Phosphagenics' TMP technology with the possibility of an expanded collaboration in the future. [ + ]

Screening process completed for phase II clinical trial of interferon to treat influenza. [ + ]

CSL, COH, ANN, BKL, NRT [ + ]

Scientists sequence genome of the N2-fixing, soil-living bacterium Azotobacter vinelandii. [ + ]

European Medicines Agency grants Clinuvel new orphan drug designation for afamelanotide. [ + ]

Two young researchers at Children’s Cancer Institute Australia for Medical Research (CCIA), Dr Joshua McCarroll and Dr Marcia Munoz, were today awarded significant funding from the Balnaves Foundation to further their promising research into childhood cancer. [ + ]

Australian researchers close to a breakthrough in cancer treatment using the body's own immune system to destroy cancerous cells. [ + ]